Sequent Research Limited - pharma in Shaikpet, Telangana, India. FY 2026 financials and compliance.
CIN U24232TS2007PLC196886 Incorporated 13 April 2007 ROC Hyderabad HQ Shaikpet, Telangana, India
Merged Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹9.52 Cr
▼ 4.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹4.7 Cr
Registered with MCA
Paid-up capital
₹4.41 Cr
Issued & subscribed
Open charges
None
Satisfied ₹32.85 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
52
Latest available

About Sequent Research Limited

Data last updated: 24 December 2025

Sequent Research Limited was a public limited company based in Shaikpet, Telangana, India, operated as a subsidiary of Sequent Scientific Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 13 April 2007.

Registered with ROC Hyderabad under CIN U24232TS2007PLC196886.

Capital: an authorised share capital of ₹4.7 Cr and a paid-up capital of ₹4.41 Cr. Formerly known as Sequent Research Private Limited. It was led by directors including Prasad Sitaram Lad and Vedprakash Shantalingappa Ragate.

Last AGM: 07 August 2025. Financial statements filed for year ended 31 March 2025. Office: Shaikpet, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.52 Cr, a decline of 4% compared to the previous year.

The company had a reported workforce of approximately 52 employees prior to being dissolved. It operated as a subsidiary of Sequent Scientific Limited.

The company was associated with 1 brand - Sequent. As per MCA filings, the company had satisfied charges of ₹32.85 Cr on record.

The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is sequent.in.

Company Details of Sequent Research Limited
CIN U24232TS2007PLC196886
Registration Number 196886
Incorporation Date 13 April 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 07 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Sequent Scientific Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    3Rd Floor Srivallis Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet Jubilee Hills, Shaikpet, Telangana, India – 500033
  • Industry
    Pharma, Pharma Contract R&D
Company report
Sequent Research Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sequent Research Limited report

Financials, compliance, directors, charges, ownership and filings for Sequent Research Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Sequent Research Limited

Sequent Research Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TS2007PLC196886, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232TS2007PLC196886 Current
U24232KA2007PLC042483 Previous
U24232KA2007PTC042483 Previous

Associated Brands with Sequent Research Limited

Sequent Research Limited operates one associated brand: SeQuent. These brands represent Sequent Research Limited's diversified market presence and brand portfolio.

Brand Description Website
APIs are developed and manufactured for therapeutic areas. sequent.in

Competitors & Alternatives of Sequent Research Limited

Brands and companies operating in the same space as Sequent Research Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 5 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Sequent Research Limited

Sequent Research Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including architecture, engineering activities, technical testing and analysis activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M4 Architecture, engineering activities, technical testing and analysis activities Locked
Premium access

Business activity turnover details for Sequent Research Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Sequent Research Limited

Sequent Research Limited is currently managed by 4 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Prasad Sitaram Lad Director 24 May 2022 4 Years 2 Months As last reported
Vedprakash Shantalingappa Ragate Director 11 Apr 2024 2 Years 4 Months As last reported
Saurav Bhala Director 13 Feb 2024 2 Years 5 Months As last reported
Rajaram Narayanan Director 11 Apr 2022 4 Years 4 Months As last reported

Financials of Sequent Research Limited FY 2025 filings available

Sequent Research Limited reported revenue of ₹9.52 Cr (down 4.00% YoY) for FY 2025.

Revenue · FY 2025
₹9.52 Cr ▼ 4.00%
Premium access

Ten-year financial statements for Sequent Research Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Sequent Research Limited

Open charges
₹0
Satisfied charges
₹32.85 Cr
Breakdown by lending institutions
Housing Development Finance Corporation Limited₹12.00 Cr
Others₹11.05 Cr
Corporation Bank₹9.80 Cr
Latest charge details
DateLenderAmountStatus
25 Jun 2015 Others ₹11.05 Cr Satisfied
20 Dec 2012 Housing Development Finance Corporation Limited ₹12 Cr Satisfied
24 Oct 2007 Corporation Bank ₹9.8 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Sequent Research Limited

View historical data on people associated with Sequent Research Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Sequent Research Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Sequent Research Limited

Premium access

GST registrations and filing compliance for Sequent Research Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Sequent Research Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Sequent Research Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sequent Research Limited

Premium access

MSME payment history for Sequent Research Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sequent Research Limited

Premium access

Corporate group structure for Sequent Research Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sequent Research Limited

Premium access

MCA filings and documents for Sequent Research Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Sequent Research Limited

Activity
07 Aug 2025
Sequent Research Limited last Annual general meeting of members was held on 07 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Sequent Research Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
11 Apr 2024
Vedprakash Shantalingappa Ragate was appointed as a Director on 11 Apr 2024 & has been associated with this company since 2 years 4 months.
Directors
13 Feb 2024
Saurav Bhala was appointed as a Director on 13 Feb 2024 & has been associated with this company since 2 years 6 months.
Directors
24 May 2022
Prasad Sitaram Lad was appointed as a Director on 24 May 2022 & has been associated with this company since 4 years 2 months.
Directors
11 Apr 2022
Rajaram Narayanan was appointed as a Director on 11 Apr 2022 & has been associated with this company since 4 years 4 months.

Recent News on Sequent Research Limited

Frequently Asked Questions about Sequent Research Limited

Sequent Research Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Sequent Research Limited is a amalgamated public limited company in the pharma sector based in Shaikpet, Telangana, India. It was incorporated on 13 April 2007 and is registered under CIN U24232TS2007PLC196886. The company was amalgamated as per MCA records and no longer exists as a legal entity.

Sequent Research Limited was incorporated on 13 April 2007. Registered with ROC Hyderabad.

The current directors of Sequent Research Limited are:

The CIN (Corporate Identification Number) of Sequent Research Limited is U24232TS2007PLC196886. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Sequent Research Limited is pharma. The company specifically operates in pharma contract r and d.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available